
Verve Ventures
Description
Verve Ventures, based in Zug, Switzerland, stands as a prominent early-stage investor in the European technology landscape. Operating as an investment platform for both private and institutional investors, the firm specializes in identifying and backing promising startups across the continent. Its unique model allows a broad base of investors to participate in venture capital opportunities, democratizing access to high-growth potential companies. Verve Ventures positions itself as a key partner for founders, offering not just capital but also strategic support and access to a wide network.
The firm primarily focuses on Seed and Series A funding rounds, targeting high-potential technology companies. While their investment scope is broad, they have a particular interest in sectors such as Artificial Intelligence, FinTech, HealthTech, ClimateTech, Enterprise Software, Deep Tech, Robotics, and Biotech. Verve Ventures typically deploys an average initial ticket size of approximately CHF 1 million (around USD 1.1 million). Beyond the initial investment, they demonstrate a strong commitment to their portfolio companies by providing significant follow-on capital, capable of investing up to CHF 5 million per company over its lifecycle.
Verve Ventures boasts an impressive track record, having deployed over CHF 700 million (approximately USD 770 million) into the European startup ecosystem. Their extensive portfolio includes more than 170 startups, underscoring their active role in fostering innovation. The firm's geographical focus spans across Europe, with a strong presence and interest in Switzerland, Germany, Austria, France, the UK, and the Nordics. This wide reach, combined with their robust investment strategy and significant capital deployment, has resulted in over 100 successful exits, solidifying their reputation as a leading early-stage venture capital firm in Europe.
Investor Profile
Verve Ventures has backed more than 243 startups, with 17 new investments in the last 12 months alone. The firm has led 36 rounds, about 15% of its total and boasts 21 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in Switzerland, France, Germany.
- Strong thematic focus on Software, Health Care, Biotechnology.
- Typical check size: $990K – $1.2M.
Stage Focus
- Series A (33%)
- Seed (30%)
- Series B (17%)
- Series Unknown (7%)
- Angel (6%)
- Series C (5%)
- Convertible Note (2%)
- Series D (1%)
Country Focus
- Switzerland (66%)
- France (9%)
- Germany (8%)
- United Kingdom (6%)
- United States (2%)
- Austria (2%)
- Belgium (2%)
- Italy (1%)
- The Netherlands (1%)
Industry Focus
- Software
- Health Care
- Biotechnology
- Information Technology
- Artificial Intelligence (Ai)
- Medical
- Medical Device
- Manufacturing
- Saas
- Robotics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.